RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 2.71% institutional investors, 0.25% insiders, and 97.04% retail investors. Blackrock is the largest institutional shareholder, holding 6.32% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	RAPT Therapeutics	2.71%	0.25%	97.04%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	2.44M	6.32%	$7.44M
Tcg crossover management	1.64M	6.07%	$42.20M
Foresite capital management vi	1.56M	5.80%	$40.30M
Rtw investments, lp	1.47M	5.46%	$37.92M
Column group	1.33M	4.93%	$10.63B
Orbimed advisors	1.09M	4.03%	$28.02M
Boone capital management	782.46K	2.90%	$20.18M
Deep track capital, lp	751.42K	2.79%	$19.38M
Vanguard group	696.19K	2.58%	$17.95M
Nantahala capital management	623.28K	2.31%	$16.07M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	1.33M	16.17%	$10.63B
Foresite capital management vi	1.56M	15.57%	$40.30M
Boone capital management	782.46K	6.62%	$20.18M
Tcg crossover management	1.64M	2.08%	$42.20M
Velan capital investment management lp	79.98K	1.94%	$2.06M
Fcpm iii services b.v.	344.24K	1.77%	$8.88M
Ikarian capital	615.00K	1.60%	$15.86M
Redmile group	552.59K	1.39%	$14.25M
Adar1 capital management	507.77K	1.23%	$13.10M
Euclidean capital	82.23K	0.89%	$2.12M

Top Buyers

Holder	Shares	% Assets	Change
Boone capital management	782.46K	6.62%	782.46K
Ikarian capital	615.00K	1.60%	615.00K
Siren	580.47K	0.59%	580.47K
Soleus capital management	537.90K	0.70%	537.90K
Fmr	248.38K	0.00%	246.44K

Top Sellers

Holder	Shares	% Assets	Change
Medicxi ventures management (jersey)	-	-	-2.79M
Bvf inc/il	-	-	-1.15M
Affinity asset advisors	-	-	-1.00M
Kingdon capital management	-	-	-575.00K
Orbimed advisors	1.09M	0.66%	-555.29K

New Positions

Holder	Shares	% Assets	Change	Value
Boone capital management	782.46K	6.62%	782.46K	$20.18M
Ikarian capital	615.00K	1.60%	615.00K	$15.86M
Siren	580.47K	0.59%	580.47K	$14.97M
Soleus capital management	537.90K	0.70%	537.90K	$13.87M
Boothbay fund management	223.86K	0.08%	223.86K	$5.77M

Sold Out

Holder	Change
Farther finance advisors	-2.00
Advisor group	-5.00
Quest partners	-5.00
Nelson, van denburg & campbell wealth management group	-7.00
Us bancorp \de\	-11.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	12	-75.51%	730,587	-95.69%	2	0.07%	4	-33.33%	5	-88.10%
Jun 30, 2025	1	-98.90%	12,437	-99.99%	-	0.01%	-	-100.00%	1	-96.15%
Mar 31, 2025	91	-4.21%	131,135,934	3.35%	243	0.23%	41	-33.87%	26	30.00%
Dec 31, 2024	90	-5.26%	114,301,746	283.56%	293	5.01%	57	50.00%	20	-25.93%
Sep 30, 2024	95	-18.10%	29,799,990	-6.32%	76	1.13%	38	-32.14%	27	-18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.00M	5.73%	-
Vanguard Total Stock Mkt Idx Inv	670.62K	4.06%	-18.51K
Fidelity Growth Compy Commingled Pl S	2.05M	1.56%	21.11K
Fidelity Growth Company Fund	1.49M	1.13%	-18.17K
Vanguard US Total Market Shares ETF	1.12M	0.85%	-
Vanguard Institutional Extnd Mkt Idx Tr	119.57K	0.72%	-54.48K
iShares Biotechnology ETF	201.44K	0.58%	-
iShares Russell 2000 ETF	703.88K	0.53%	-
Fidelity Growth Company K6	481.38K	0.36%	-2.94K
Federated Hermes MDT SCC Institutional	461.23K	0.35%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 05, 2024	Brockstedt Dirk G.	CHIEF SCIENTIFIC OFFICER	Sell	$20.46K
Dec 21, 2023	HO WILLIAM	Chief Medical Officer	Sell	$54.20K
Nov 28, 2023	HO WILLIAM	Chief Medical Officer	Sell	$20.58K
Oct 03, 2023	HO WILLIAM	Chief Medical Officer	Sell	$39.42K
Aug 18, 2023	HO WILLIAM	Chief Medical Officer	Sell	$47.30K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	1
2023 Q4	-	3
2023 Q3	-	1

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 2.71%, followed by 0.25% insiders and 97.04% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 45.24%, which RAPT Therapeutics falls below.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Blackrock (2.44M shares, 6.32%), Tcg crossover management (1.64M shares, 6.07%), and Foresite capital management vi (1.56M shares, 5.80%). Together, they hold 18.19% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

Yes, BlackRock owns 6.32% of RAPT Therapeutics, totaling 2.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.44M$. In the last quarter, BlackRock decreased its holdings by -32.323K shares, a -1.31% change.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.17% of its assets in 1.33M RAPT Therapeutics shares, valued at 10.63B$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of RAPT Therapeutics shares, with 5.73% of its total shares outstanding invested in 2M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools